New Cancer Blood Test May Bolster Mesothelioma Diagnostic Tools
A new cancer blood test may make boost the accuracy of current screening tools and allow doctors to detect malignant mesothelioma and other hard-to-find cancers earlier. The test is called a multi-cancer early detection (MCED) test. The US company Grail developed it and researchers at the Cleveland Clinic tested it on more than 3,500 patients. They found that it correctly identified cancer in more than half of cases. The test was even more accurate in rare cancer types for which no screening test is available. Malignant mesothelioma was not specifically mentioned in the report. But it is an extremely rare cancer. The method used by the new cancer blood test suggests that it could be useful for finding mesothelioma, too. …